Clinical data analysis is one of the powerful learning methods in cancer research. Several analysis methods have been used for detection purposes in computational pathology. However, little information is known about the model features. Here, we described Kaplan-Meier plotter analysis model as a powerful tool with new features. The model combines fellow up threshold, disease stage, and race to ensure better validation for genes as prognostic biomarkers in early disease stages. The proposed model is evaluated for the relevance role of Rab1A, an oncogene, in renal cancer early prognosis on the benchmark datasets from The Human Protein Atlas. We found Rab1A overexpression in human renal cancer has potential role in early prognosis of the disease and it is associated with poor prognosis (p<0.05). Our model results were also confirmed in an independent dataset in The Human Protein Atlas. Together, our studies emphasize the role of Rab1A in human malignancies and identify Rab1A as a new prognostic predictor for human renal cancer.